Pasar al contenido principal

EL RECABLEADO DEL INTERACTOMA COMO UNA NUEVA VIA PARA EL DESARROLLO DE ANTIMICROBIANOS CONTRA INFECCIONES CAUSADAS POR PSEUDOMONAS AERUGINOSA

PID2020-114627RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 24
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

From In Vitro Promise to In Vivo Reality, An Instructive Account of Infection Model Evaluation of Antimicrobial Peptides

  • Carrera-Aubesart, Adam|||0000-0001-6196-1647
  • Li, Jiarui|||0000-0001-5556-3001
  • Contreras, Estefanía|||0000-0002-8645-2790
  • Bello Madruga, Roberto|||0009-0003-8474-3951
  • Torrent, Marc|||0000-0001-6567-3474
  • Andreu Martínez, David|||0000-0002-6317-6666
Antimicrobial peptides (AMPs) are regarded as a promising alternative to traditional antibiotics in the face of ever-increasing resistance. However, many AMPs fail to progress into clinics due to unexpected difficulties found in preclinical in vivo phases. Our research has focused on crotalicidin (Ctn), an AMP from snake venom, and a fragment thereof, Ctn[15-34], with improved in vitro antimicrobial and anticancer activities and remarkable serum stability. As the retroenantio versions of both AMPs maintained favorable profiles, in this work, we evaluate the in vivo efficacy of both the native-sequence AMPs and their retroenantio counterparts in a murine infection model with Acinetobacter baumannii. A significant reduction in bacterial levels is found in the mice treated with Ctn[15-34]. However, contrary to expectations, the retroenantio analogs either exhibit toxicity or lack efficacy when administered to mice. Our findings underscore the critical importance of in vivo infection model evaluation to fully calibrate the therapeutic potential of AMPs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Targeting N-terminal domain dynamics to prevent binding

  • Corbella, Marina
  • Moreira, Cátia
  • Bello Madruga, Roberto|||0009-0003-8474-3951
  • Torrent, Marc|||0000-0001-6567-3474
  • Kamerlin, Shina C. L.|||0000-0002-3190-1173
  • Blair, Jessica M. A.
  • Sancho Vaello, Enea|||0000-0003-1383-2001
Efflux is one of the mechanisms employed by Gram-negative bacteria to become resistant to routinely used antibiotics. The inhibition of efflux by targeting their regulators is a promising strategy to re-sensitize bacterial pathogens to antibiotics. AcrAB-TolC is the main resistance-nodulation-division efflux pump in Enterobacteriaceae. MarA is an AraC/XylS family global regulator that regulates more than 40 genes related to the antimicrobial resistance phenotype, including acrAB. The aim of this work was to understand the role of the N-terminal helix of MarA in the mechanism of DNA binding. An N-terminal deletion of MarA showed that the N-terminal helix is critical for recognition of the functional marboxes. By engineering two double cysteine variants of MarA that form a disulfide bond between the N-terminal helix and the hydrophobic core of one of the helices in direct DNA contact, and combining in vitro electrophoretic mobility assays, in vivo measurements of acrAB transcription using a GFP reporter system, and molecular dynamic simulations, it was shown that the immobilization of the N-terminal helix of MarA prevents binding to DNA. This inhibited conformation seems to be universal for the monomeric members of the AraC/XylS family, as suggested by additional molecular dynamics simulations of the two-domain protein Rob. These results point to the N-terminal helix of the AraC/XylS family monomeric regulators as a promising target for the development of inhibitors.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

PyAMPA, a high-throughput prediction and optimization tool for antimicrobial peptides

  • Ramos-Llorens, Marc|||0000-0002-5194-1279
  • Bello Madruga, Roberto|||0009-0003-8474-3951
  • Valle García, Javier|||0000-0002-6787-8286
  • Andreu Martínez, David|||0000-0002-6317-6666
  • Torrent, Marc|||0000-0001-6567-3474
This paper introduces PyAMPA, a new bioinformatics platform designed for the discovery and optimization of antimicrobial peptides (AMPs). It addresses the urgent need for new antimicrobials due to the rise of antibiotic-resistant infections. PyAMPA, with its five predictive modules -AMPScreen, AMPValidate, AMPSolve, AMPMutate and AMPOptimize, enables high-throughput screening of proteomes to identify potential AMP motifs and optimize them for clinical use. Its unique approach, combining prediction, design, and optimization tools, makes PyAMPA a robust solution for developing new AMP-based therapies, offering a significant advance in combatting antibiotic resistance.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

From in vitro promise to in vivo reality: An instructive account of infection model evaluation of antimicrobial peptides

  • Carrera-Aubesart, Adam
  • Li, Jiarui
  • Contreras, Estefanía
  • Bello Madruga, Roberto
  • Torrent Burgas, Marc
  • Andreu Martínez, David
Antimicrobial peptides (AMPs) are regarded as a promising alternative to traditional antibiotics in the face of ever-increasing resistance. However, many AMPs fail to progress into clinics due to unexpected difficulties found in preclinical in vivo phases. Our research has focused on crotalicidin (Ctn), an AMP from snake venom, and a fragment thereof, Ctn[15-34], with improved in vitro antimicrobial and anticancer activities and remarkable serum stability. As the retroenantio versions of both AMPs maintained favorable profiles, in this work, we evaluate the in vivo efficacy of both the native-sequence AMPs and their retroenantio counterparts in a murine infection model with Acinetobacter baumannii. A significant reduction in bacterial levels is found in the mice treated with Ctn[15-34]. However, contrary to expectations, the retroenantio analogs either exhibit toxicity or lack efficacy when administered to mice. Our findings underscore the critical importance of in vivo infection model evaluation to fully calibrate the therapeutic potential of AMPs., Grants from MCIN, Spanish Ministry of Science and Innovation (PID2020-113184RB-C22/AEI/10.13039/501100011033 to D.A. and PID2020-114627RB-I00/AEI/10.13039/501100011033 to M.T. were funded by MCIN/AEI; PDC2021-121544-I00/AEI/10.13039/501100011033 to M.T. was funded by MCIN/AEI and European Union Next GenerationEU/PRTR). Work at UPF was also funded by La Caixa Health Foundation (project HR17_00409 to D.A.) and by the MCIN “María de Maeztu” Program for Units of Excellence in R&D (CEX2018-000792-M) to the UPF Department of Medicine and Life Sciences at (MELIS-UPF).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

PyAMPA: a high-throughput prediction and optimization tool for antimicrobial peptides

  • Ramos Llorens, Marc
  • Bello Madruga, Roberto
  • Valle, Javier
  • Andreu Martínez, David
  • Torrent Burgas, Marc
The alarming rise of antibiotic-resistant bacterial infections is driving efforts to develop alternatives to conventional antibiotics. In this context, antimicrobial peptides (AMPs) have emerged as promising candidates for their ability to target a broad range of microorganisms. However, the development of AMPs with optimal potency, selectivity, and/or stability profiles remains a challenge. To address it, computational tools for predicting AMP properties and designing novel peptides have gained increasing attention. PyAMPA is a novel platform for AMP discovery. It consists of five modules, namely AMPScreen, AMPValidate, AMPSolve, AMPMutate, and AMPOptimize, that allow high-throughput proteome inspection, candidate screening, and optimization through point-mutation and genetic algorithms. The platform also offers additional tools for predicting and evaluating AMP properties, including antimicrobial and cytotoxic activity, and peptide half-life. By providing innovative and accessible inroads into AMP motifs in proteomes, PyAMPA will enable advances in AMP development and potential translation into clinically useful molecules. PyAMPA is available at: https://github.com/SysBioUAB/PyAMPA. Importance: This paper introduces PyAMPA, a new bioinformatics platform designed for the discovery and optimization of antimicrobial peptides (AMPs). It addresses the urgent need for new antimicrobials due to the rise of antibiotic-resistant infections. PyAMPA, with its five predictive modules -AMPScreen, AMPValidate, AMPSolve, AMPMutate and AMPOptimize, enables high-throughput screening of proteomes to identify potential AMP motifs and optimize them for clinical use. Its unique approach, combining prediction, design, and optimization tools, makes PyAMPA a robust solution for developing new AMP-based therapies, offering a significant advance in combatting antibiotic resistance., Grants from MCIN, Spanish Ministry of Science and Innovation (PID2020-113184RB-C22/AEI/10.13039/501100011033 to D.A. and PID2020-114627RB-I00/AEI/10.13039/501100011033 to M.T. were funded by MCIN/AEI; PDC2021-121544-I00/AEI/10.13039/501100011033 to M.T. was funded by MCIN/AEI and European Union Next GenerationEU/ PRTR). Work at UPF was also supported by La Caixa Health Foundation (grant HR17-00409 to D.A.) and by MCIN “María de Maeztu” Program for Units of Excellence in R&D (CEX2018-000792-M) to the UPF Department of Medicine and Life Sciences at (MELIS-UPF). Work at UAB was further supported by a 2022 grant from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). R.B.M. is recipient of a pre-doctoral FPI scholarship (PRE2021-097678) from the Spanish Ministerio de Ciencia e Innovación.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Mining the heparinome for cryptic antimicrobial peptides that selectively kill Gram-negative bacteria

  • Bello Madruga, Roberto
  • Sandín, Daniel
  • Valle, Javier
  • Gómez Borrego, Jordi
  • Comas, Laura
  • Larrosa, María Nieves
  • González-López, Juan José
  • Jiménez, María Ángeles
  • Andreu Martínez, David
  • Torrent Burgas, Marc
Glycosaminoglycan (GAG)-binding proteins regulating essential processes such as cell growth and migration are essential for cell homeostasis. As both GAGs and the lipid A disaccharide core of Gram-negative bacteria contain negatively charged disaccharide units, we hypothesized that GAG-binding proteins could also recognize LPS and enclose cryptic antibiotic motifs. Here, we report novel antimicrobial peptides (AMPs) derived from heparin-binding proteins (HBPs), with specific activity against Gram-negative bacteria and high LPS binding. We used computational tools to locate antimicrobial regions in 82% of HBPs, most of those colocalizing with putative heparin-binding sites. To validate these results, we synthesized five candidates [HBP-1-5] that showed remarkable activity against Gram-negative bacteria, as well as a strong correlation between heparin and LPS binding. Structural characterization of these AMPs shows that heparin or LPS recognition promotes a conformational arrangement that favors binding. Among all analogs, HBP-5 displayed the highest affinity for both heparin and LPS, with antimicrobial activities against Gram-negative bacteria at the nanomolar range. These results suggest that GAG-binding proteins are involved in LPS recognition, which allows them to act also as antimicrobial proteins. Some of the peptides reported here, particularly HBP-5, constitute a new class of AMPs with specific activity against Gram-negative bacteria., Financial support from the Spanish Ministry of Economy and Innovation (PDC2021-121544-I00 funded by MCIN/AEI/10.13039/501100011033 and European Union Next Generation EU/ PRTR to MT; project PID2020-114627RB-I00 funded by MCIN/AEI/10.13039/501100011033 to MT; PID2020-112821GB-I00 funded by MCIN/AEI/10.13039/501100011033 to MAJ and PID2020-113184RB-C22 to DA), the Departament de Recerca i Universitats de la Generalitat de Catalunya (2023PROD00021 to MT), and from La Caixa Banking Foundation (HR17-00409, to DA). This work has been co-financed by the Spanish Ministry of Science and Innovation with funds from the European Union Next Generation EU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) ESCMID2022 and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health. Work at UPF was funded by the MCI María de Maeztu network of Units of Excellence. NMR experiments were performed in the “Manuel Rico” NMR laboratory (LMR) of the Spanish National Research Council (CSIC), a node of the Spanish Large-Scale National Facility (ICTS R-LRB). DS and RBM are recipients of pre-doctoral a FPI scholarship (PRE2018-083243 and PRE2021-097678, respectively) from the Spanish Ministry of Science and Innovation.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Examining topoisomers of a snake-venom-derived peptide for improved antimicrobial and antitumoral properties

  • Carrera-Aubesart, Adam
  • Defaus, Sira
  • Pérez-Peinado, Clara, 1991-
  • Sandín, Daniel
  • Torrent Burgas, Marc
  • Jiménez, M. Ángeles
  • Andreu Martínez, David
Ctn[15-34], the C-terminal section of crotalicidin (Ctn), a cathelicidin from a South American pit viper, is an antimicrobial and antitumoral peptide with remarkably longer stability in human serum than the parent Ctn. In this work, a set of topoisomers of both Ctn and Ctn[15-34], including the retro, enantio, and retroenantio versions, were synthesized and tested to investigate the structural requirements for activity. All topoisomers were as active as the cognate sequences against Gram-negative bacteria and tumor cells while slightly more toxic towards normal cells. More importantly, the enhanced serum stability of the D-amino-acid-containing versions suggests that such topoisomers must be preferentially considered as future antimicrobial and anticancer peptide leads., Financial support from the Spanish Ministry of Economy and Innovation (grant AGL2017-84097-C2-2-R), from the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033 grants PID2020-113184RB-C22; PID2020-112821GB-I00 and PID2020-114627RB-I00; MCIN/AEI/10.13039/501100011033/FEDER PDC2021-121544-I00), from the EU (Next GenerationEU/PRTR) and from La Caixa Banking Foundation (HR17-00409) is acknowledged.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Antimicrobial peptides can generate tolerance by lag and interfere with antimicrobial therapy

  • Sandín, Daniel
  • Valle, Javier
  • Morata, Jordi
  • Andreu Martínez, David
  • Torrent Burgas, Marc
Antimicrobial peptides (AMPs) are widely distributed molecules secreted mostly by cells of the innate immune system to prevent bacterial proliferation at the site of infection. As with classic antibiotics, continued treatment with AMPs can create resistance in bacteria. However, whether AMPs can generate tolerance as an intermediate stage towards resistance is not known. Here, we show that the treatment of Escherichia coli with different AMPs induces tolerance by lag, particularly for those peptides that have internal targets. This tolerance can be detected as different morphological and physiological changes, which depend on the type of peptide molecule the bacterium has been exposed to. In addition, we show that AMP tolerance can also affect antibiotic treatment. The genomic sequencing of AMP-tolerant strains shows that different mutations alter membrane composition, DNA replication, and translation. Some of these mutations have also been observed in antibiotic-resistant strains, suggesting that AMP tolerance could be a relevant step in the development of antibiotic resistance. Monitoring AMP tolerance is relevant vis-á-vis the eventual therapeutic use of AMPs and because cross-tolerance might favor the emergence of resistance against conventional antibiotic treatments., Financial support from the Spanish Ministry of Economy and Innovation (PDC2021-121544-I00 funded by MCIN/AEI /10.13039/501100011033 and European Union Next GenerationEU/ PRTR to M.T.; project PID2020-114627RB-I00 funded by MCIN/ AEI /10.13039/501100011033 to M.T. and AGL2017-84097-C2-2-R to D.A.), and from La Caixa Banking Foundation (HR17-00409, to D.A.). Work at UPF was funded by the MCI María de Maeztu network of Units of Excellence. D.S. is recipient of pre-doctoral a FPI scholarship (PRE2018-083243) from the Spanish Ministerio de Ciencia e Innovación.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A high-throughput approach to predict A-to-I effects on RNA structure indicates a change of double-stranded content in noncoding RNAs

  • Delli Ponti, Riccardo, 1987-
  • Broglia, Laura
  • Vandelli, Andrea
  • Armaos, Alexandros, 1989-
  • Torrent Burgas, Marc
  • Sanchez de Groot, Natalia
  • Tartaglia, Gian Gaetano
RNA molecules undergo a number of chemical modifications whose effects can alter their structure and molecular interactions. Previous studies have shown that RNA editing can impact the formation of ribonucleoprotein complexes and influence the assembly of membrane-less organelles such as stress granules. For instance, N6-methyladenosine (m6A) enhances SG formation and N1-methyladenosine (m1A) prevents their transition to solid-like aggregates. Yet, very little is known about adenosine to inosine (A-to-I) modification that is very abundant in human cells and not only impacts mRNAs but also noncoding RNAs. Here, we introduce the CROSSalive predictor of A-to-I effects on RNA structure based on high-throughput in-cell experiments. Our method shows an accuracy of 90% in predicting the single and double-stranded content of transcripts and identifies a general enrichment of double-stranded regions caused by A-to-I in long intergenic noncoding RNAs (lincRNAs). For the individual cases of NEAT1, NORAD, and XIST, we investigated the relationship between A-to-I editing and interactions with RNA-binding proteins using available CLIP data and catRAPID predictions. We found that A-to-I editing is linked to the alteration of interaction sites with proteins involved in phase separation, which suggests that RNP assembly can be influenced by A-to-I. CROSSalive is available at http://service.tartaglialab.com/new_submission/crossalive., The research leading to these results has been supported by European Research Council [RIBOMYLOME_309545 and ASTRA_855923], the H2020 projects [IASIS_727658 and INFORE_825080], the Spanish Ministry of Science and Innovation (RYC2019-026752-I, PID2020-117454RA-I00/AEI/10.13039/501100011033, and PID2020-114627RB-I00/AEI/10.13039/501100011033) and L'Oréal-UNESCO For Women in Science Programme 2021.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The C-terminus of panusin, a lobster β-defensin, is crucial for optimal antimicrobial activity and serum stability

  • Bello Madruga, Roberto
  • Valle, Javier
  • Jiménez, M. Ángeles
  • Torrent Burgas, Marc
  • Montero Alejo, Vivian
  • Andreu Martínez, David
β-defensins are one of the most abundant and studied families of antimicrobial peptides (AMPs). Because of their selective toxicity to bacterial membranes and a broad spectrum of microbicidal action, β-defensins are regarded as potential therapeutic agents. This work focuses on a β-defensin-like AMP from the spiny lobster Panulirus argus (hereafter referred to as panusin or PaD). This AMP is structurally related to mammalian defensins via the presence of an αβ domain stabilized by disulfide bonds. Previous studies of PaD suggest that its C-terminus (Ct_PaD) contains the main structural determinants of antibacterial activity. To confirm this hypothesis, we made synthetic versions of PaD and Ct_PaD to determine the influence of the C-terminus on antimicrobial activity, cytotoxicity, proteolytic stability, and 3D structure. After successful solid-phase synthesis and folding, antibacterial assays of both peptides showed truncated Ct_PaD to be more active than native PaD, confirming the role of the C-terminus in activity and suggesting that cationic residues in that region enhance binding to negatively charged membranes. On the other hand, neither PaD nor Ct_PaD were hemolytic or cytotoxic in human cells. Proteolysis in human serum was also studied, showing high (>24 h) t1/2 values for PaD and lower but still considerable for Ct_PaD, indicating that the missing native disulfide bond in Ct_PaD alters protease resistance, albeit not decisively. NMR-2D experiments in water agree with the results obtained by circular dichroism (CD), where in SDS micelles, CD showed both peptides adopting an increasingly ordered structure in a hydrophobic environment, in tune with their ability to perturb bacterial membrane systems. In conclusion, while the β-defensin features of PaD are confirmed as advantageous in terms of antimicrobial activity, toxicity, and protease stability, the results of the present work suggest that these same features are preserved, even enhanced, in the structurally simpler Ct_PaD, which must therefore be viewed as a valuable lead for the development of novel anti-infectives., Grants from MCIN, Spanish Ministry of Science and Innovation (PID2020-113184RB-C22/AEI/10.13039/501100011033 to D.A.; PID2020-114627RB-I00/AEI/10.13039/501100011033 and PDC2021-121544-I00/AEI/10.13039/501100011033 to M.T.; and PID2020-112821GB-I00/AEI/10.13039/501100011033 to M.A.J.) are acknowledged. Work at UPF also supported by La Caixa Health Foundation (grant HR17-00409 to D.A.) and by MCIN “María de Maeztu” Program for Units of Excellence in R&D (CEX2018-000792-M)) to the UPF Department of Medicine and Life Sciences at (MELIS-UPF). Work at UAB further supported by a 2022 grant from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). NMR experiments performed at the Manuel Rico NMR laboratory (LMR) of the Spanish National Research Council (CSIC), a node of the Spanish Large-Scale National Facility (ICTS R-LRB). R.B.M. is recipient of a pre-doctoral FPI scholarship (PRE2021-097678) from the Spanish Ministerio de Ciencia e Innovación.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Examining Topoisomers of a Snake-Venom-Derived Peptide for Improved Antimicrobial and Antitumoral Properties

  • Carrera-Aubesart, Adam
  • Defaus, Sira
  • Pérez-Peinado, Clara
  • Sandín, Daniel
  • Torrent, Marc
  • Jiménez, M. Angeles
  • Andreu, David
13 pags., 6 figs., 2 tabs. -- This article belongs to the Special Issue Peptides of Natural Origin as Leads for Drug Discovery: From Native Structures to Peptidomimetics, Peptide-Conjugates, and Peptide-Nanoparticles 2.0, Ctn[15-34], the C-terminal section of crotalicidin (Ctn), a cathelicidin from a South American pit viper, is an antimicrobial and antitumoral peptide with remarkably longer stability in human serum than the parent Ctn. In this work, a set of topoisomers of both Ctn and Ctn[15-34], including the retro, enantio, and retroenantio versions, were synthesized and tested to investigate the structural requirements for activity. All topoisomers were as active as the cognate sequences against Gram-negative bacteria and tumor cells while slightly more toxic towards normal cells. More importantly, the enhanced serum stability of the D-amino-acid-containing versions suggests that such topoisomers must be preferentially considered as future antimicrobial and anticancer peptide leads., Financial support from the Spanish Ministry of Economy and Innovation (grant AGL2017-84097-C2-2-R), from the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033 grants PID2020-113184RB-C22; PID2020-112821GB-I00 and PID2020-114627RB-I00; MCIN/AEI/10.13039/501100011033/FEDER PDC2021-121544-I00), from the EU (Next GenerationEU/PRTR) and from La Caixa Banking Foundation (HR17-00409) is acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The C-Terminus of Panusin, a Lobster β-Defensin, Is Crucial for Optimal Antimicrobial Activity and Serum Stability

  • Bello-Madruga, Roberto
  • Valle, Javier
  • Jiménez, M. Angeles
  • Torrent, Marc
  • Montero-Alejo, Vivian
  • Andreu, David
β-defensins are one of the most abundant and studied families of antimicrobial peptides (AMPs). Because of their selective toxicity to bacterial membranes and a broad spectrum of microbicidal action, β-defensins are regarded as potential therapeutic agents. This work focuses on a β-defensin-like AMP from the spiny lobster Panulirus argus (hereafter referred to as panusin or PaD). This AMP is structurally related to mammalian defensins via the presence of an αβ domain stabilized by disulfide bonds. Previous studies of PaD suggest that its C-terminus (Ct_PaD) contains the main structural determinants of antibacterial activity. To confirm this hypothesis, we made synthetic versions of PaD and Ct_PaD to determine the influence of the C-terminus on antimicrobial activity, cytotoxicity, proteolytic stability, and 3D structure. After successful solid-phase synthesis and folding, antibacterial assays of both peptides showed truncated Ct_PaD to be more active than native PaD, confirming the role of the C-terminus in activity and suggesting that cationic residues in that region enhance binding to negatively charged membranes. On the other hand, neither PaD nor Ct_PaD were hemolytic or cytotoxic in human cells. Proteolysis in human serum was also studied, showing high (>24 h) t1/2 values for PaD and lower but still considerable for Ct_PaD, indicating that the missing native disulfide bond in Ct_PaD alters protease resistance, albeit not decisively. NMR-2D experiments in water agree with the results obtained by circular dichroism (CD), where in SDS micelles, CD showed both peptides adopting an increasingly ordered structure in a hydrophobic environment, in tune with their ability to perturb bacterial membrane systems. In conclusion, while the β-defensin features of PaD are confirmed as advantageous in terms of antimicrobial activity, toxicity, and protease stability, the results of the present work suggest that these same features are preserved, even enhanced, in the structurally simpler Ct_PaD, which must therefore be viewed as a valuable lead for the development of novel anti-infectives., Grants from MCIN, Spanish Ministry of Science and Innovation (PID2020-113184RB-C22/AEI/10.13039/501100011033 to D.A.; PID2020-114627RB-I00/AEI/10.13039/501100011033 and PDC2021-121544-I00/AEI/10.13039/501100011033 to M.T.; and PID2020-112821GB-I00/AEI/10.13039/501100011033 to M.A.J.) are acknowledged. Work at UPF also supported by La Caixa Health Foundation (grant HR17-00409 to D.A.) and by MCIN “María de Maeztu” Program for Units of Excellence in R&D (CEX2018-000792-M)) to the UPF Department of Medicine and Life Sciences at (MELIS-UPF). Work at UAB further supported by a 2022 grant from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). NMR experiments performed at the Manuel Rico NMR laboratory (LMR) of the Spanish National Research Council (CSIC), a node of the Spanish Large-Scale National Facility (ICTS R-LRB). R.B.M. is recipient of a pre-doctoral FPI scholarship (PRE2021-097678) from the Spanish Ministerio de Ciencia e Innovación., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (referencia del instituto). Por ejemplo: With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2018-000792-M)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mining the heparinome for cryptic antimicrobial peptides that selectively kill Gram-negative bacteria

  • Bello-Madruga, Roberto
  • Sandín, Daniel
  • Valle, Javier
  • Gómez, Jordi
  • Comas, Laura
  • Larrosa, María Nieves
  • González-López, Juan José
  • Jiménez, M. Angeles
  • Andreu, David
  • Torrent, Marc
Glycosaminoglycan (GAG)-binding proteins regulating essential processes such as cell growth and migration are essential for cell homeostasis. As both GAGs and the lipid A disaccharide core of Gram-negative bacteria contain negatively charged disaccharide units, we hypothesized that GAG-binding proteins could also recognize LPS and enclose cryptic antibiotic motifs. Here, we report novel antimicrobial peptides (AMPs) derived from heparin-binding proteins (HBPs), with specific activity against Gram-negative bacteria and high LPS binding. We used computational tools to locate antimicrobial regions in 82% of HBPs, most of those colocalizing with putative heparin-binding sites. To validate these results, we synthesized five candidates [HBP-1-5] that showed remarkable activity against Gram-negative bacteria, as well as a strong correlation between heparin and LPS binding. Structural characterization of these AMPs shows that heparin or LPS recognition promotes a conformational arrangement that favors binding. Among all analogs, HBP-5 displayed the highest affinity for both heparin and LPS, with antimicrobial activities against Gram-negative bacteria at the nanomolar range. These results suggest that GAG-binding proteins are involved in LPS recognition, which allows them to act also as antimicrobial proteins. Some of the peptides reported here, particularly HBP-5, constitute a new class of AMPs with specific activity against Gram-negative bacteria., Financial support from the Spanish Ministry of Economy and Innovation (PDC2021-121544-I00 funded by MCIN/AEI/10.13039/501100011033 and European Union Next Generation EU/ PRTR to MT; project PID2020-114627RB-I00 funded by MCIN/AEI/10.13039/501100011033 to MT; PID2020-112821GB-I00 funded by MCIN/AEI/10.13039/501100011033 to MAJ and PID2020-113184RB-C22 to DA), the Departament de Recerca iUniversitats de la Generalitat de Catalunya (2023PROD00021 to MT), and from La Caixa Banking Foundation (HR17-00409, to DA). This work has been co-financed by the Spanish Ministry of Science and Innovation with funds from the European Union Next Generation EU, from the Recovery, Transformationand Resilience Plan (PRTR-C17.I1), European Society of Clinical Microbiologyand Infectious Diseases (ESCMID) ESCMID2022 and from the Autonomous Community of Catalonia within the framework of the Biotechnology PlanApplied to Health. Work at UPF was funded by the MCI María de Maeztu network of Units of Excellence. NMR experiments were performed in the“Manuel Rico” NMR laboratory (LMR) of the Spanish National ResearchCouncil (CSIC), a node of the Spanish Large-Scale National Facility (ICTS R-LRB). DS and RBM are recipients of pre-doctoral a FPI scholarship (PRE2018-083243 and PRE2021-097678, respectively) from the Spanish Ministry ofScience and Innovation, Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Antimicrobial peptides can generate tolerance by lag and interfere with antimicrobial therapy

  • Sandín, Daniel
  • Valle, Javier
  • Morata, Jordi
  • Andreu Martínez, David
  • Torrent Burgas, Marc
Antimicrobial peptides (AMPs) are widely distributed molecules secreted mostly by cells of the innate immune system to prevent bacterial proliferation at the site of infection. As with classic antibiotics, continued treatment with AMPs can create resistance in bacteria. However, whether AMPs can generate tolerance as an intermediate stage towards resistance is not known. Here, we show that the treatment of Escherichia coli with different AMPs induces tolerance by lag, particularly for those peptides that have internal targets. This tolerance can be detected as different morphological and physiological changes, which depend on the type of peptide molecule the bacterium has been exposed to. In addition, we show that AMP tolerance can also affect antibiotic treatment. The genomic sequencing of AMP-tolerant strains shows that different mutations alter membrane composition, DNA replication, and translation. Some of these mutations have also been observed in antibiotic-resistant strains, suggesting that AMP tolerance could be a relevant step in the development of antibiotic resistance. Monitoring AMP tolerance is relevant vis-á-vis the eventual therapeutic use of AMPs and because cross-tolerance might favor the emergence of resistance against conventional antibiotic treatments., Financial support from the Spanish Ministry of Economy and Innovation (PDC2021-121544-I00 funded by MCIN/AEI /10.13039/501100011033 and European Union Next GenerationEU/ PRTR to M.T.; project PID2020-114627RB-I00 funded by MCIN/ AEI /10.13039/501100011033 to M.T. and AGL2017-84097-C2-2-R to D.A.), and from La Caixa Banking Foundation (HR17-00409, to D.A.). Work at UPF was funded by the MCI María de Maeztu network of Units of Excellence. D.S. is recipient of pre-doctoral a FPI scholarship (PRE2018-083243) from the Spanish Ministerio de Ciencia e Innovación.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A high-throughput approach to predict A-to-I effects on RNA structure indicates a change of double-stranded content in noncoding RNAs

  • Delli Ponti, Riccardo, 1987-
  • Broglia, Laura
  • Vandelli, Andrea
  • Armaos, Alexandros, 1989-
  • Torrent Burgas, Marc
  • Sanchez de Groot, Natalia
  • Tartaglia, Gian Gaetano
RNA molecules undergo a number of chemical modifications whose effects can alter their structure and molecular interactions. Previous studies have shown that RNA editing can impact the formation of ribonucleoprotein complexes and influence the assembly of membrane-less organelles such as stress granules. For instance, N6-methyladenosine (m6A) enhances SG formation and N1-methyladenosine (m1A) prevents their transition to solid-like aggregates. Yet, very little is known about adenosine to inosine (A-to-I) modification that is very abundant in human cells and not only impacts mRNAs but also noncoding RNAs. Here, we introduce the CROSSalive predictor of A-to-I effects on RNA structure based on high-throughput in-cell experiments. Our method shows an accuracy of 90% in predicting the single and double-stranded content of transcripts and identifies a general enrichment of double-stranded regions caused by A-to-I in long intergenic noncoding RNAs (lincRNAs). For the individual cases of NEAT1, NORAD, and XIST, we investigated the relationship between A-to-I editing and interactions with RNA-binding proteins using available CLIP data and catRAPID predictions. We found that A-to-I editing is linked to the alteration of interaction sites with proteins involved in phase separation, which suggests that RNP assembly can be influenced by A-to-I. CROSSalive is available at http://service.tartaglialab.com/new_submission/crossalive., The research leading to these results has been supported by European Research Council [RIBOMYLOME_309545 and ASTRA_855923], the H2020 projects [IASIS_727658 and INFORE_825080], the Spanish Ministry of Science and Innovation (RYC2019-026752-I, PID2020-117454RA-I00/AEI/10.13039/501100011033, and PID2020-114627RB-I00/AEI/10.13039/501100011033) and L'Oréal-UNESCO For Women in Science Programme 2021.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

From in vitro promise to in vivo reality: An instructive account of infection model evaluation of antimicrobial peptides

  • Carrera-Aubesart, Adam
  • Li, Jiarui
  • Contreras, Estefanía
  • Bello Madruga, Roberto
  • Torrent Burgas, Marc
  • Andreu Martínez, David
Antimicrobial peptides (AMPs) are regarded as a promising alternative to traditional antibiotics in the face of ever-increasing resistance. However, many AMPs fail to progress into clinics due to unexpected difficulties found in preclinical in vivo phases. Our research has focused on crotalicidin (Ctn), an AMP from snake venom, and a fragment thereof, Ctn[15-34], with improved in vitro antimicrobial and anticancer activities and remarkable serum stability. As the retroenantio versions of both AMPs maintained favorable profiles, in this work, we evaluate the in vivo efficacy of both the native-sequence AMPs and their retroenantio counterparts in a murine infection model with Acinetobacter baumannii. A significant reduction in bacterial levels is found in the mice treated with Ctn[15-34]. However, contrary to expectations, the retroenantio analogs either exhibit toxicity or lack efficacy when administered to mice. Our findings underscore the critical importance of in vivo infection model evaluation to fully calibrate the therapeutic potential of AMPs., Grants from MCIN, Spanish Ministry of Science and Innovation (PID2020-113184RB-C22/AEI/10.13039/501100011033 to D.A. and PID2020-114627RB-I00/AEI/10.13039/501100011033 to M.T. were funded by MCIN/AEI; PDC2021-121544-I00/AEI/10.13039/501100011033 to M.T. was funded by MCIN/AEI and European Union Next GenerationEU/PRTR). Work at UPF was also funded by La Caixa Health Foundation (project HR17_00409 to D.A.) and by the MCIN “María de Maeztu” Program for Units of Excellence in R&D (CEX2018-000792-M) to the UPF Department of Medicine and Life Sciences at (MELIS-UPF).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The C-terminus of panusin, a lobster β-defensin, is crucial for optimal antimicrobial activity and serum stability

  • Bello Madruga, Roberto
  • Valle, Javier
  • Jiménez, M. Ángeles
  • Torrent Burgas, Marc
  • Montero Alejo, Vivian
  • Andreu Martínez, David
β-defensins are one of the most abundant and studied families of antimicrobial peptides (AMPs). Because of their selective toxicity to bacterial membranes and a broad spectrum of microbicidal action, β-defensins are regarded as potential therapeutic agents. This work focuses on a β-defensin-like AMP from the spiny lobster Panulirus argus (hereafter referred to as panusin or PaD). This AMP is structurally related to mammalian defensins via the presence of an αβ domain stabilized by disulfide bonds. Previous studies of PaD suggest that its C-terminus (Ct_PaD) contains the main structural determinants of antibacterial activity. To confirm this hypothesis, we made synthetic versions of PaD and Ct_PaD to determine the influence of the C-terminus on antimicrobial activity, cytotoxicity, proteolytic stability, and 3D structure. After successful solid-phase synthesis and folding, antibacterial assays of both peptides showed truncated Ct_PaD to be more active than native PaD, confirming the role of the C-terminus in activity and suggesting that cationic residues in that region enhance binding to negatively charged membranes. On the other hand, neither PaD nor Ct_PaD were hemolytic or cytotoxic in human cells. Proteolysis in human serum was also studied, showing high (>24 h) t1/2 values for PaD and lower but still considerable for Ct_PaD, indicating that the missing native disulfide bond in Ct_PaD alters protease resistance, albeit not decisively. NMR-2D experiments in water agree with the results obtained by circular dichroism (CD), where in SDS micelles, CD showed both peptides adopting an increasingly ordered structure in a hydrophobic environment, in tune with their ability to perturb bacterial membrane systems. In conclusion, while the β-defensin features of PaD are confirmed as advantageous in terms of antimicrobial activity, toxicity, and protease stability, the results of the present work suggest that these same features are preserved, even enhanced, in the structurally simpler Ct_PaD, which must therefore be viewed as a valuable lead for the development of novel anti-infectives., Grants from MCIN, Spanish Ministry of Science and Innovation (PID2020-113184RB-C22/AEI/10.13039/501100011033 to D.A.; PID2020-114627RB-I00/AEI/10.13039/501100011033 and PDC2021-121544-I00/AEI/10.13039/501100011033 to M.T.; and PID2020-112821GB-I00/AEI/10.13039/501100011033 to M.A.J.) are acknowledged. Work at UPF also supported by La Caixa Health Foundation (grant HR17-00409 to D.A.) and by MCIN “María de Maeztu” Program for Units of Excellence in R&D (CEX2018-000792-M)) to the UPF Department of Medicine and Life Sciences at (MELIS-UPF). Work at UAB further supported by a 2022 grant from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). NMR experiments performed at the Manuel Rico NMR laboratory (LMR) of the Spanish National Research Council (CSIC), a node of the Spanish Large-Scale National Facility (ICTS R-LRB). R.B.M. is recipient of a pre-doctoral FPI scholarship (PRE2021-097678) from the Spanish Ministerio de Ciencia e Innovación.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

PyAMPA: a high-throughput prediction and optimization tool for antimicrobial peptides

  • Ramos Llorens, Marc
  • Bello Madruga, Roberto
  • Valle, Javier
  • Andreu Martínez, David
  • Torrent Burgas, Marc
The alarming rise of antibiotic-resistant bacterial infections is driving efforts to develop alternatives to conventional antibiotics. In this context, antimicrobial peptides (AMPs) have emerged as promising candidates for their ability to target a broad range of microorganisms. However, the development of AMPs with optimal potency, selectivity, and/or stability profiles remains a challenge. To address it, computational tools for predicting AMP properties and designing novel peptides have gained increasing attention. PyAMPA is a novel platform for AMP discovery. It consists of five modules, namely AMPScreen, AMPValidate, AMPSolve, AMPMutate, and AMPOptimize, that allow high-throughput proteome inspection, candidate screening, and optimization through point-mutation and genetic algorithms. The platform also offers additional tools for predicting and evaluating AMP properties, including antimicrobial and cytotoxic activity, and peptide half-life. By providing innovative and accessible inroads into AMP motifs in proteomes, PyAMPA will enable advances in AMP development and potential translation into clinically useful molecules. PyAMPA is available at: https://github.com/SysBioUAB/PyAMPA. Importance: This paper introduces PyAMPA, a new bioinformatics platform designed for the discovery and optimization of antimicrobial peptides (AMPs). It addresses the urgent need for new antimicrobials due to the rise of antibiotic-resistant infections. PyAMPA, with its five predictive modules -AMPScreen, AMPValidate, AMPSolve, AMPMutate and AMPOptimize, enables high-throughput screening of proteomes to identify potential AMP motifs and optimize them for clinical use. Its unique approach, combining prediction, design, and optimization tools, makes PyAMPA a robust solution for developing new AMP-based therapies, offering a significant advance in combatting antibiotic resistance., Grants from MCIN, Spanish Ministry of Science and Innovation (PID2020-113184RB-C22/AEI/10.13039/501100011033 to D.A. and PID2020-114627RB-I00/AEI/10.13039/501100011033 to M.T. were funded by MCIN/AEI; PDC2021-121544-I00/AEI/10.13039/501100011033 to M.T. was funded by MCIN/AEI and European Union Next GenerationEU/ PRTR). Work at UPF was also supported by La Caixa Health Foundation (grant HR17-00409 to D.A.) and by MCIN “María de Maeztu” Program for Units of Excellence in R&D (CEX2018-000792-M) to the UPF Department of Medicine and Life Sciences at (MELIS-UPF). Work at UAB was further supported by a 2022 grant from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). R.B.M. is recipient of a pre-doctoral FPI scholarship (PRE2021-097678) from the Spanish Ministerio de Ciencia e Innovación.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Mining the heparinome for cryptic antimicrobial peptides that selectively kill Gram-negative bacteria

  • Bello Madruga, Roberto
  • Sandín, Daniel
  • Valle, Javier
  • Gómez Borrego, Jordi
  • Comas, Laura
  • Larrosa, María Nieves
  • González-López, Juan José
  • Jiménez, María Ángeles
  • Andreu Martínez, David
  • Torrent Burgas, Marc
Glycosaminoglycan (GAG)-binding proteins regulating essential processes such as cell growth and migration are essential for cell homeostasis. As both GAGs and the lipid A disaccharide core of Gram-negative bacteria contain negatively charged disaccharide units, we hypothesized that GAG-binding proteins could also recognize LPS and enclose cryptic antibiotic motifs. Here, we report novel antimicrobial peptides (AMPs) derived from heparin-binding proteins (HBPs), with specific activity against Gram-negative bacteria and high LPS binding. We used computational tools to locate antimicrobial regions in 82% of HBPs, most of those colocalizing with putative heparin-binding sites. To validate these results, we synthesized five candidates [HBP-1-5] that showed remarkable activity against Gram-negative bacteria, as well as a strong correlation between heparin and LPS binding. Structural characterization of these AMPs shows that heparin or LPS recognition promotes a conformational arrangement that favors binding. Among all analogs, HBP-5 displayed the highest affinity for both heparin and LPS, with antimicrobial activities against Gram-negative bacteria at the nanomolar range. These results suggest that GAG-binding proteins are involved in LPS recognition, which allows them to act also as antimicrobial proteins. Some of the peptides reported here, particularly HBP-5, constitute a new class of AMPs with specific activity against Gram-negative bacteria., Financial support from the Spanish Ministry of Economy and Innovation (PDC2021-121544-I00 funded by MCIN/AEI/10.13039/501100011033 and European Union Next Generation EU/ PRTR to MT; project PID2020-114627RB-I00 funded by MCIN/AEI/10.13039/501100011033 to MT; PID2020-112821GB-I00 funded by MCIN/AEI/10.13039/501100011033 to MAJ and PID2020-113184RB-C22 to DA), the Departament de Recerca i Universitats de la Generalitat de Catalunya (2023PROD00021 to MT), and from La Caixa Banking Foundation (HR17-00409, to DA). This work has been co-financed by the Spanish Ministry of Science and Innovation with funds from the European Union Next Generation EU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) ESCMID2022 and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health. Work at UPF was funded by the MCI María de Maeztu network of Units of Excellence. NMR experiments were performed in the “Manuel Rico” NMR laboratory (LMR) of the Spanish National Research Council (CSIC), a node of the Spanish Large-Scale National Facility (ICTS R-LRB). DS and RBM are recipients of pre-doctoral a FPI scholarship (PRE2018-083243 and PRE2021-097678, respectively) from the Spanish Ministry of Science and Innovation.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Examining topoisomers of a snake-venom-derived peptide for improved antimicrobial and antitumoral properties

  • Carrera-Aubesart, Adam
  • Defaus, Sira
  • Pérez-Peinado, Clara, 1991-
  • Sandín, Daniel
  • Torrent Burgas, Marc
  • Jiménez, M. Ángeles
  • Andreu Martínez, David
Ctn[15-34], the C-terminal section of crotalicidin (Ctn), a cathelicidin from a South American pit viper, is an antimicrobial and antitumoral peptide with remarkably longer stability in human serum than the parent Ctn. In this work, a set of topoisomers of both Ctn and Ctn[15-34], including the retro, enantio, and retroenantio versions, were synthesized and tested to investigate the structural requirements for activity. All topoisomers were as active as the cognate sequences against Gram-negative bacteria and tumor cells while slightly more toxic towards normal cells. More importantly, the enhanced serum stability of the D-amino-acid-containing versions suggests that such topoisomers must be preferentially considered as future antimicrobial and anticancer peptide leads., Financial support from the Spanish Ministry of Economy and Innovation (grant AGL2017-84097-C2-2-R), from the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033 grants PID2020-113184RB-C22; PID2020-112821GB-I00 and PID2020-114627RB-I00; MCIN/AEI/10.13039/501100011033/FEDER PDC2021-121544-I00), from the EU (Next GenerationEU/PRTR) and from La Caixa Banking Foundation (HR17-00409) is acknowledged.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Examining Topoisomers of a Snake-Venom-Derived Peptide for Improved Antimicrobial and Antitumoral Properties

  • Carrera-Aubesart, Adam|||0000-0001-6196-1647
  • Defaus, Sira|||0000-0002-3106-458X
  • Pérez-Peinado, Clara
  • Sandín, Daniel|||0000-0002-2805-0208
  • Torrent, Marc|||0000-0001-6567-3474
  • Jiménez, María Ángeles|||0000-0001-6835-5850
  • Andreu Martínez, David|||0000-0002-6317-6666
Ctn[15-34], the C-terminal section of crotalicidin (Ctn), a cathelicidin from a South American pit viper, is an antimicrobial and antitumoral peptide with remarkably longer stability in human serum than the parent Ctn. In this work, a set of topoisomers of both Ctn and Ctn[15-34], including the retro, enantio, and retroenantio versions, were synthesized and tested to investigate the structural requirements for activity. All topoisomers were as active as the cognate sequences against Gram-negative bacteria and tumor cells while slightly more toxic towards normal cells. More importantly, the enhanced serum stability of the D-amino-acid-containing versions suggests that such topoisomers must be preferentially considered as future antimicrobial and anticancer peptide leads.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Analysis of Host-Bacteria Protein Interactions Reveals Conserved Domains and Motifs That Mediate Fundamental Infection Pathways

  • Gómez Borrego, Jordi|||0000-0003-1963-5455
  • Torrent, Marc|||0000-0001-6567-3474
Adhesion and colonization of host cells by pathogenic bacteria depend on protein-protein interactions (PPIs). These interactions are interesting from the pharmacological point of view since new molecules that inhibit host-pathogen PPIs would act as new antimicrobials. Most of these interactions are discovered using high-throughput methods that may display a high false positive rate. The absence of curation of these databases can make the available data unreliable. To address this issue, a comprehensive filtering process was developed to obtain a reliable list of domains and motifs that participate in PPIs between bacteria and human cells. From a structural point of view, our analysis revealed that human proteins involved in the interactions are rich in alpha helix and disordered regions and poorer in beta structure. Disordered regions in human proteins harbor short sequence motifs that are specifically recognized by certain domains in pathogenic proteins. The most relevant domain-domain interactions were validated by AlphaFold, showing that a proper analysis of host-pathogen PPI databases can reveal structural conserved patterns. Domain-motif interactions, on the contrary, were more difficult to validate, since unstructured regions were involved, where AlphaFold could not make a good prediction. Moreover, these interactions are also likely accommodated by post-translational modifications, especially phosphorylation, which can potentially occur in 25-50% of host proteins. Hence, while common structural patterns are involved in host-pathogen PPIs and can be retrieved from available databases, more information is required to properly infer the full interactome. By resolving these issues, and in combination with new prediction tools like Alphafold, new classes of antimicrobials could be discovered from a more detailed understanding of these interactions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Antimicrobial Peptides Can Generate Tolerance by Lag and Interfere with Antimicrobial Therapy

  • Sandín, Daniel|||0000-0002-2805-0208
  • Valle García, Javier|||0000-0002-6787-8286
  • Morata, Jordi|||0000-0002-6146-4322
  • Andreu Martínez, David|||0000-0002-6317-6666
  • Torrent, Marc|||0000-0001-6567-3474
Antimicrobial peptides (AMPs) are widely distributed molecules secreted mostly by cells of the innate immune system to prevent bacterial proliferation at the site of infection. As with classic antibiotics, continued treatment with AMPs can create resistance in bacteria. However, whether AMPs can generate tolerance as an intermediate stage towards resistance is not known. Here, we show that the treatment of Escherichia coli with different AMPs induces tolerance by lag, particularly for those peptides that have internal targets. This tolerance can be detected as different morphological and physiological changes, which depend on the type of peptide molecule the bacterium has been exposed to. In addition, we show that AMP tolerance can also affect antibiotic treatment. The genomic sequencing of AMP-tolerant strains shows that different mutations alter membrane composition, DNA replication, and translation. Some of these mutations have also been observed in antibiotic-resistant strains, suggesting that AMP tolerance could be a relevant step in the development of antibiotic resistance. Monitoring AMP tolerance is relevant vis-á-vis the eventual therapeutic use of AMPs and because cross-tolerance might favor the emergence of resistance against conventional antibiotic treatments.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The C-Terminus of Panusin, a Lobster β-Defensin, Is Crucial for Optimal Antimicrobial Activity and Serum Stability

  • Bello Madruga, Roberto|||0009-0003-8474-3951
  • Valle García, Javier|||0000-0002-6787-8286
  • Jiménez, María Ángeles|||0000-0001-6835-5850
  • Torrent, Marc|||0000-0001-6567-3474
  • Montero-Alejo, Vivian|||0000-0002-0089-7925
  • Andreu Martínez, David|||0000-0002-6317-6666
β-defensins are one of the most abundant and studied families of antimicrobial peptides (AMPs). Because of their selective toxicity to bacterial membranes and a broad spectrum of microbicidal action, β-defensins are regarded as potential therapeutic agents. This work focuses on a β-defensin-like AMP from the spiny lobster Panulirus argus (hereafter referred to as panusin or PaD). This AMP is structurally related to mammalian defensins via the presence of an αβ domain stabilized by disulfide bonds. Previous studies of PaD suggest that its C-terminus (Ct_PaD) contains the main structural determinants of antibacterial activity. To confirm this hypothesis, we made synthetic versions of PaD and Ct_PaD to determine the influence of the C-terminus on antimicrobial activity, cytotoxicity, proteolytic stability, and 3D structure. After successful solid-phase synthesis and folding, antibacterial assays of both peptides showed truncated Ct_PaD to be more active than native PaD, confirming the role of the C-terminus in activity and suggesting that cationic residues in that region enhance binding to negatively charged membranes. On the other hand, neither PaD nor Ct_PaD were hemolytic or cytotoxic in human cells. Proteolysis in human serum was also studied, showing high (.